Israel - inglês - Ministry of Health

teva israel ltd - cetrimide; chlorhexidine hydrochloride - cream - cetrimide 0.5 %w/w; chlorhexidine hydrochloride 0.1 %w/w - chlorhexidine, combinations - chlorhexidine, combinations - first aid antiseptic for external use in treatment for minor injuries, wounds and burns.

Israel - inglês - Ministry of Health

teva israel ltd - tolnaftate - cream - tolnaftate 1 % - other antifungals for topical use - topical treatment of superficial dermatomycoses.

Israel - inglês - Ministry of Health

ben shimon floris ltd, israel - hydrogen peroxide - solution - hydrogen peroxide 3 %w/w - other antiseptics and disinfectants - antiseptic.

Israel - inglês - Ministry of Health

teva israel ltd - loratadine - tablets - loratadine 10 mg - other antihistamines for systemic use - relief of symptoms of allergy in seasonal allergic rhinitis, perennial allergic rhinitis, chronic urticaria.

União Europeia - inglês - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Israel - inglês - Ministry of Health

medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established

Israel - inglês - Ministry of Health

teva israel ltd - xylometazoline hydrochloride - nasal spray, solution - xylometazoline hydrochloride 1 mg/ml - xylometazoline - rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.

Israel - inglês - Ministry of Health

teva israel ltd - xylometazoline hydrochloride - nasal spray, solution - xylometazoline hydrochloride 0.5 mg/ml - xylometazoline - rapid symptomatic relief of nasal decongestion up to 10 hours in children aged 2-12 years.

Armênia - inglês - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmstandard-leksredstva jsc - fabomotizole (fabomotizole dihydrochloride) - tablets - 10mg